StonvexLoading…
StonvexStonvexStonvexCore line items from LGND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $64.76M | $51.72M | $268.09M | $208.42M | $92.96M |
Operating Income | Not available | $17.37M | $41.00M | $27.16M | $-27.77M |
Net Income | Not available | $-13.35M | $124.45M | $79.67M | $-37.60M |
EPS (Diluted) | $2.07 | $-0.67 | $6.13 | $3.95 | $-1.95 |
Total Assets | Not available | $1.53B | $1.56B | $1.48B | $948.60M |
Total Liabilities | Not available | $534.78M | $543.42M | $526.60M | $120.08M |
Cash & Equivalents | Not available | $115.08M | $174.93M | $139.38M | $67.67M |
Free Cash Flow OCF − CapEx | Not available | $48.46M | $48.91M | $3.00M | $-10.07M |
Shares Outstanding | Not available | 20.03M | 19.77M | 19.66M | 19.41M |